Skip to main content

Results of a nationwide audit of repeat non-steroidal anti-inflammatory drug prescribing in Wales



Author/s Deslandes P, K H, Bracchi R, Jacks S, Routledge PA
Year 2012
Type of publication Conference proceeding
Link https://doi.org/10.1111/j.2042-7174.2012.00235.x
Abstract

The aim of this study was to audit repeat non-steroidal antiinflammatory drug (NSAID) prescribing across Wales using a nationally-agreed audit toolkit. Data were received for 9397 patients receiving NSAIDs, of whom 57% had one or more risk factor associated with an increased incidence of NSAID-associated adverse events. Diclofenac was the most commonly prescribed NSAID (30% of 9157 subjects) despite an increased cardiovascular risk profile for this NSAID compared with some others . Prescribers should consider factors increasing the risk of NSAID-associated adverse events when prescribing these agents.

Follow AWTTC: